The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope

Journal of General Virology

Volumn 79, Issue 11, 1998, Pages 2709-2716

  Buratti, Emanuele ^a   McLain, Lesley ^b   Tisminetzky, Sergio ^a   Cleveland, S Matthew ^b   Dimmock, Nigel J ^b   Baralle, Francisco E ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY;

ANIMALIA; COWPEA MOSAIC VIRUS; FLOCK HOUSE VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031737117     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-11-2709     Document Type: Article

References (34)

1. Amit, A., Mariuzza, R. A., Phillips, S. E. V. & Poljak, R. J. (1986). Three-dimensional structure of an antigen-antibody complex at 2·8 Å resolution. Science 233, 747-753.
2. Broliden, P.-A., Von Gegerfelt, A., Clapham, P., Rosen, J., Fenyo, E.-M., Wahren, B. & Broliden, K. (1992). Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proceedings of the National Academy of Sciences, USA 89, 461-465.
3. Buratti, E., Tisminetzky, S. G., Scodeller, E. S. & Baralle, F. E. (1996). Conformational display of two neutralizing epitopes of HIV-1 gp41 on the flock house virus capsid protein. Journal of Immunological Methods 197, 7-18.
4. Buratti, E., Tisminetzky, S. G., D'Agaro, P. & Baralle, F. E. (1997). A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE. Journal of Virology 71, 2457-2462.
5. Chanh, T. C., Dreesman, G. R., Kanda, P., Linette, G. P., Sparrow, J. T., Ho, D. D. & Kennedy, R. C. (1986). Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO Journal 5, 3065-3071.
6. Cheinsong-Popov, R., Callow, D., Beddows, S., Shaunak, S., Wasi, C., Kalcebu, P., Gilks, C., Petrascu, I. V., Garaev, M. M., Watts, D. M., Constantine, N. T. & Weber, J. N. (1992). Geographic diversity of human immunodeficiency virus type 1: serologie reactivity to Env epitopes and relationship to neutralization. Journal of Infectious Diseases 165, 256-261.
7. Chen, Y. H. & Dierich, M. P. (1996). Identification of a second site in HIV-1 gp41 mediating binding to cells. Immunology Letters 52, 153-156.
8. Dalgleish, A. G., Chanh, T. C., Kennedy, R. C., Kanda, P., Clapham, P. R. & Weiss, R. A. (1988). Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology 165, 209-215.
9. Davis, D., Chaudhri, B., Stephens, D. M., Carne, C. A., Willers, C. & Lachmann, P. J. (1990). The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens. Journal of General Virology 71, 1975-1983.
10. Evans, D. J., McKeating, J., Meredith, J. M., Burke, K. L., Katrak, K., John, A., Ferguson, M., Minor, P. D., Weiss, R. A. & Almond, J. W. (1989). An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339, 385-388.
11. Gallagher, D. M. (1992). HIV/AIDS: the epidemic continues. Imprint 39, 62.
12. Ho, D. D., McKeating, J. A., Li, X. L., Moudgil, T., Daar, E. S., Sun, N.-C. & Robinson, J. E. (1991). Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. Journal of Virology 65, 489-493.
13. Jackson, D. C., Poumbourios, P. & White, D. O. (1988). Simultaneous binding of two monoclonal antibodies to epitopes separated in sequence by only three amino acid residues. Molecular Immunology 25, 465-471.
14. Kalyan, N. K., Lee, S. G., Wilhelm, J., Pisano, M. R., Hum, W. T., Hsiao, C. L., Davis, A. R., Eichberg, J. W., Robert-Guroff, M. & Hung, P. P. (1994). Immunogenicity of recombinant influenza virus haemagglutinin-carrying peptides from the envelope protein of human immunodeficiency virus type 1. Vaccine 12, 753-760.
15. Kennedy, R. C., Henkel, R. D., Pauletti, D., Allan, J. S., Lee, T. H., Essex, M. & Dreesman, G. R. (1986). Antiserum to a synthetic peptide recognizes HTLV-III envelope glycoprotein. Science 231, 1556-1559.
16. McLain, L. & Dimmock, N. J. (1994). Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. Journal of General Virology 75, 1457-1460.
17. McLain, L., Porta, C., Lomonossoff, G. P., Durrani, Z. & Dimmock, N. J. (1995). Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus. AIDS Research and Human Retroviruses 11, 327-334.
18. McLain, L., Durrani, Z., Wisniewski, L. A., Porta, C., Lomonossoff, G. P. & Dimmock, N. J. (1996a). A plant virus-HIV-1 chimera stimulates antibodies that neutralize HIV-1. In Vaccine 96, pp. 311-316. Edited by F. Brown, D. R. Burton, J. Collier, J. Mekalonos & E. Norrby. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
19. McLain, L., Durrani, Z., Wisniewski, L. A., Porta, C., Lomonossoff, G. P. & Dimmock, N. J. (1996b). Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. Vaccine 14, 799-810.
20. Modrow, S., Hahn, B. H., Shaw, G. M., Gallo, R. C., Wong-Staal, F. & Wolf, H. (1987). Computer assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. Journal of Virology 61, 570-578.
21. + human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules. AIDS Research and Human Retroviruses 9, 209-217.
22. Moore, J. P., Sattentau, Q. J., Wyatt, R. & Sodroski, J. (1994a). Mapping the topology of the human immunodeficiency virus glycoprotein gp120 with a panel of monoclonal antibodies. Journal of Virology 68, 469-484.
23. Moore, J. P., Cao, Y., Conley, A. J., Wyatt, R., Robinson, J., Gorny, M. K., Zolla-Pazner, S., Ho, D. D. & Koup, R. A. (1994b). Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assays. Journal of Acquired Immune Deficiency Syndromes 7, 332-339.
24. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Ruker, F. & Katinger, H. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. Journal of Virology 67, 6642-6647.
25. Newton, S. M. C., Joys, T. M., Anderson, S. A., Kennedy, R. C., Hovi, M. E. & Stocker, B. A. D. (1995). Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. Research in Microbiology 146, 203-216.
26. Pincus, S. H., Messer, K. G., Schwartz, D. H., Lewis, G. K., Graham, B. S., Blattner, W. A. & Fisher, G. (1993). Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees. Journal of Clinical Investigation 91, 1987-1996.
27. Pincus, S. H., Messer, K. G. & Hu, S.-L. (1994). Effect of non protective vaccination on antibody response to subsequent human immunodeficiency virus infection. Journal of Clinical Investigation 93, 140-146.
28. Sattentau, Q. J., Zolla-Pazner, S. & Poignard, P. (1995). Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. Virology 206, 713-717.
29. Tisminetzky, S. G., Scodeller, E. A., Evangelista, P., Chen, Y., Schiappacassi, M., Porro, F., Bizik, F., Zacchi, T., Lunazzi, G., Miertus, S. & Baralle, F. E. (1994). Immunoreactivity of chimeric proteins carrying the HIV-1 epitope IGPGRAF: correlation between predicted conformation and antigenicity. FEBS Letters 353, 1-4.
30. Tsoukas, C. M. & Bernard, N. F. (1994). Markers predicting progression of human immunodeficiency virus-related disease. Clinical Microbiology Reviews 7, 14-28.
31. Vella, C., Minor, P. D., Weller, I. V. D., Jenkins, O., Evans, D. & Almond, J. (1991). Recognition of poliovirus/HIV chimaeras by antisera from individuals with HIV infection. AIDS 5, 425-430.
32. Vella, C., Ferguson, M., Dunn, G., Meloen, R., Langedijk, H., Evans, D. & Minor, P. D. (1993). Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera. Journal of General Virology 74, 2603-2607.
33. Weiss, R. A. (1993). How does HIV cause AIDS? Science 260, 1273-1279.
34. Wilson, I. A. & Stanfield, R. L. (1993). Antibody-antigen interactions. Current Opinion in Structural Biology 3, 113-118.